Conclusions: These findings imply that miR-182-5p promotes NSCLC progression by targeting EPAS1 and is, therefore, a potential indicator of tumor recurrence in NSCLC patients. The gene discussed is EPAS1; the disease is non-small cell lung carcinoma.